Celera Shifts Focus To Clinical Diagnostics, Deserting Drug Development
This article was originally published in The Pink Sheet Daily
In revamping its business strategy away from drug development, the biotech firm assumes sole ownership of Celera Diagnostics from sister company Applied Biosystems.
You may also be interested in...
After losing bidding war for Guidant, J&J charges winning firms with using leaked information.
Some state lawmakers contend that industry's voluntary code of ethics is insufficient, according to Kyphon's chief compliance officer.
Agency compliance head Tim Ulatowski says he's not concerned about the scientific exchange of information on products.